Relafen 750, structurally known as its salt potassium, presents a unique case from a biochemical point of view . Its mechanism of action primarily involves the reduction of cyclooxygenase pathways, specifically COX-2, producing a reduction in prostaglandin formation. This process effectively diminishes discomfort and redness associated with various